Fulcrum Therapeutics (FULC)
(Real Time Quote from BATS)
$7.13 USD
0.00 (0.00%)
Updated Apr 26, 2024 10:20 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.44 | 0.00% |
Earnings Summary
For their last quarter, Fulcrum Therapeutics (FULC) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 9.09%. Look out for FULC's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year decrease of 7.32%.
Earnings History
Price & Consensus
Zacks News for FULC
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics
FULC: What are Zacks experts saying now?
Zacks Private Portfolio Services